Catalyst Wire Dossier Catalyst Wire Dossier

Durva

Durvalumab · AstraZeneca
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Durva, covering 2025-05-01 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: TRUDI: TDXD+Durva in HER2+/Low IBC [Phase 2]

See pricing